Trials / Recruiting
RecruitingNCT07220876
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial of the Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 165 (estimated)
- Sponsor
- Avisi Technologies Inc. · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial
Detailed description
To evaluate the safety and effectiveness of VisiPlate Aqueous Shunt to lower intraocular pressure (IOP) in subjects with open-angle glaucoma for whom medical and surgical treatments have failed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VisiPlate Glaucoma Implant | Implant (micro-shunt) for glaucoma patients |
Timeline
- Start date
- 2025-11-07
- Primary completion
- 2027-10-01
- Completion
- 2027-10-01
- First posted
- 2025-10-24
- Last updated
- 2025-12-15
Locations
12 sites across 2 countries: United States, South Africa
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07220876. Inclusion in this directory is not an endorsement.